Overview
Heikki Kuusanmaki practices in Helsinki, Finland. Kuusanmaki is rated as an Experienced expert by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. Their top areas of expertise are Adult T-Cell Leukemia, Leukemia, Acute Myeloid Leukemia (AML), and Acute Megakaryoblastic Leukemia.
Their clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult T-Cell LeukemiaKuusanmaki isDistinguished. Learn about Adult T-Cell Leukemia.
- Advanced
- Acute Myeloid Leukemia (AML)Kuusanmaki isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaKuusanmaki isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Kuusanmaki isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaKuusanmaki isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Chronic Myelogenous Leukemia (CML)Kuusanmaki isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic T-Cell Leukemia (CTCL)Kuusanmaki isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).